The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative efficacy of zanubrutinib (ZANU) versus rituximab (RTX) in relapsed marginal zone lymphoma (MZL): Matching-adjusted indirect comparison (MAIC).
 
Catherine Thieblemont
Honoraria - Abbvie; Bayer; Celgene; Gilead Sciences; Incyte; Janssen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Kite/Gilead; Novartis; Roche
 
Kaijun Wang
No Relationships to Disclose
 
Sam Keeping
Employment - PRECISIONHeor
Research Funding - BeiGene
 
Ina Zhang
Employment - PRECISIONHeor
Research Funding - BeiGene
 
Keri Yang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
Research Funding - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Boxiong Tang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Leyla Mohseninejad
Consulting or Advisory Role - BeiGene
Research Funding - BeiGene